The biofilm formation and antibiotic resistance of bacterial profile from endotracheal tube of patients admitted to intensive care unit in southwest of Iran.

Ventilator-associated pneumonia (VAP) is a prevalent nosocomial illness in mechanically ventilated patients. Hence, the aim of this study was to investigate the pattern of antibiotic resistance and biofilm formation of bacterial profiles from Endotracheal Tubes of patients hospitalized in an intensive care unit in southwest Iran. According to the standard operating method, the microbiological laboratory conducts bacteria culture and susceptibility testing on endotracheal Tube samples suspected of carrying a bacterial infection. The Clinical and laboratory standards institute (CLSI) techniques are used to determine the Antimicrobial resistance (AMR) of bacterial isolates to antibiotics using the disk diffusion method. The crystal violet staining method was used to assess the biofilm-forming potential of isolates in a 96-well microtiter plate. In total, (51%) GPBs were included in this study. The isolated GPB were coagulase-negative Staphylococcus (16%), S. aureus (14%). In total, (40%) of GNB were included in this study. The isolated GNB were Klebsiella spp. (36%), A. baumannii (22%), P. aeruginosa (35%). (32%) bacterial strains were MDR and (29%) strains were XDR. The results of biofilm formation showed (72%) were biofilm producers. VAP is a common and severe nosocomial infection in mechanically ventilated patients. Controlling biofilm formation, whether on the ET or in the oropharyngeal cavity, is thus an important technique for treating VAP. Colistin and linezolid are antibiotics that are effective against practically all resistant GNB and GPB isolates.

Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.

Surface-growing antibiotic-resistant pathogenic bacteria such as Escherichia coli and Staphylococcus aureus are emerging as a global health challenge due to dilemmas in clinical treatment. Furthermore, their pathogenesis, including increasingly serious antimicrobial resistance and biofilm formation, makes them challenging to treat by conventional therapy. Therefore, the development of novel antivirulence strategies will undoubtedly provide a path forward in combatting these resistant bacterial infections. In this regard, we developed novel biosurfactant-coated nanoparticles to combine the antiadhesive/antibiofilm properties of rhamnolipid (RHL)-coated Fe3O4 nanoparticles (NPs) with each of the p-coumaric acid (p-CoA) and gallic acid (GA) antimicrobial drugs by using the most available polymer common coatings (PVA) to expand the range of effective antibacterial drugs, as well as a mechanism for their synergistic effect via a simple method of preparation. Mechanistically, the average size of bare Fe3O4 NPs was ~15 nm, while RHL-coated Fe3O4@PVA@p-CoA/GA was about ~254 nm, with a drop in zeta potential from -18.7 mV to -34.3 mV, which helped increase stability. Our data show that RHL-Fe3O4@PVA@p-CoA/GA biosurfactant NPs can remarkably interfere with bacterial growth and significantly inhibited biofilm formation to more than 50% via downregulating IcaABCD and CsgBAC operons, which are responsible for slime layer formation and curli fimbriae production in S. aureus and E. coli, respectively. The novelty regarding the activity of RHL-Fe3O4@PVA@p-CoA/GA biosurfactant NPs reveals their potential effect as an alternative multitarget antivirulence candidate to minimize infection severity by inhibiting biofilm development. Therefore, they could be used in antibacterial coatings and wound dressings in the future. IMPORTANCE Antimicrobial resistance poses a great threat and challenge to humanity. Therefore, the search for alternative ways to target and eliminate microbes from plant, animal, and marine microorganisms is one of the world's concerns today. Furthermore, the extraordinary capacity of S. aureus and E. coli to resist standard antibacterial drugs is the dilemma of all currently used remedies. Methicillin-resistant S. aureus (MRSA) and vancomycin-resistant S. aureus (VRSA) have become widespread, leading to no remedies being able to treat these threatening pathogens. The most widely recognized serotypes that cause severe foodborne illness are E. coli O157:H7, O26:H11, and O78:H10, and they display increasing antimicrobial resistance rates. Therefore, there is an urgent need for an effective therapy that has dual action to inhibit biofilm formation and decrease bacterial growth. In this study, the synthesized RHL-Fe3O4@PVA@p-CoA/GA biosurfactant NPs have interesting properties, making them excellent candidates for targeted drug delivery by inhibiting bacterial growth and downregulating biofilm-associated IcaABCD and CsgBAC gene loci.

Investigation of the Bacterial Contamination and Antibiotic Susceptibility Profile of Bacteria Isolated from Bottled Drinking Water.

The purpose of this study was to assess the bacteriological quality in some domestic bottled waters marketed in Al Anbar Province of Iraq. In total, 120 samples were collected from 20 different domestic bottled water companies. The current study findings demonstrated that the positive total bacterial count for aerobic bacteria was 20 CFU/ml (16.6%) out of 120 samples. From 120 tested samples, coliform bacteria had a much lower count of 13 CFU/ml (10.8%). The bacteriological analysis tests of this study showed that the brand bottled water of Alhilwa had the highest mean of total bacterial count at 485 CFU/ml, followed by Alwafi and Araco, which found at mean of 283 and 196 CFU/ml, respectively. The other brands of bottled waters included Sawa and Izmir, which had given lower mean of bacterial count at 87 and 58 CFU/ml, respectively, while all other tested brands of bottled waters had zero content of total bacterial count. According to the biomedical tests and Vitek2 system employed for this study, the isolated bacterial species as contaminants in bottled waters were Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. The results of this study showed that Pseudomonas aeruginosa was sensitive to all tested antibiotics, but the Escherichia coli was resistance to amoxicillin, azithromycin, ceftazidime, and cefixime. The Klebsiella pneumonia demonstrated sensitivity to all tested antibiotics except the cefixime. Therefore, antibiotics belonging to the types of penicillin, carbapenem, and quinolones can be considered the best medicine for treating infections caused by the bacteria diagnosed in this study. In conclusion, the findings of this study showed that some domestic bottled waters sold in markets and shops in Al Anbar Province have bacteriological contents that are within permitted ranges for Iraqi and WHO standards. IMPORTANCE Researchers analyzed how lifestyle factors affect the overall health of people with bacterial infections from the water. The article describes significance of the research because many people do not have access to clean, safe drinking water where this water is essential to life, and many die of waterborne bacterial infections. So, the purpose of the article is to draw attention to the major factors of the most dangerous bacteria transmitted through water marketed in Al Anbar Province of Iraq: Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Furthermore, our specific significant contribution has been to show the most important treatments for treating infections caused by the bacteria diagnosed in this study.